# Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

> **NCT00378781** · NA · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Heparin
- **DRUG:** Minocycline-EDTA

## Key facts

- **NCT ID:** NCT00378781
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study withdrawn.
- **Last updated:** 2012-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00378781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00378781, "Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00378781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*